ATE90355T1 - Weiche steroide mit anti-entzuendungswirkung. - Google Patents

Weiche steroide mit anti-entzuendungswirkung.

Info

Publication number
ATE90355T1
ATE90355T1 AT87907186T AT87907186T ATE90355T1 AT E90355 T1 ATE90355 T1 AT E90355T1 AT 87907186 T AT87907186 T AT 87907186T AT 87907186 T AT87907186 T AT 87907186T AT E90355 T1 ATE90355 T1 AT E90355T1
Authority
AT
Austria
Prior art keywords
beta
agents
inflammatory effects
hydroxyandrost
alkoxy
Prior art date
Application number
AT87907186T
Other languages
English (en)
Inventor
Nicholas S Bodor
Original Assignee
Nicholas S Bodor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas S Bodor filed Critical Nicholas S Bodor
Application granted granted Critical
Publication of ATE90355T1 publication Critical patent/ATE90355T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT87907186T 1987-10-13 1987-10-13 Weiche steroide mit anti-entzuendungswirkung. ATE90355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87907186A EP0334853B1 (de) 1987-10-13 1987-10-13 Weiche steroide mit anti-entzündungswirkung
PCT/US1987/002590 WO1989003390A1 (en) 1987-10-13 1987-10-13 Soft steroids having anti-inflammatory activity

Publications (1)

Publication Number Publication Date
ATE90355T1 true ATE90355T1 (de) 1993-06-15

Family

ID=22202600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907186T ATE90355T1 (de) 1987-10-13 1987-10-13 Weiche steroide mit anti-entzuendungswirkung.

Country Status (4)

Country Link
EP (1) EP0334853B1 (de)
AT (1) ATE90355T1 (de)
DE (1) DE3786174T2 (de)
WO (1) WO1989003390A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
PT2348032E (pt) 2000-08-05 2015-10-14 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-'(2-furanilcarboxil)oxi]-11.beta.-hidroxi-16.alfa.- metil-3-oxo-androsta-1,4-dieno-17-carbotióico como um agente anti-inflamatório
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
CA2445839A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2006506445A (ja) * 2002-08-28 2006-02-23 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 治療処置の方法
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
AU2004285592B2 (en) * 2003-11-03 2010-02-18 Norton Healthcare, Ltd. Soft steroid compositions for use in dry powder inhalers
US7579335B2 (en) 2005-01-10 2009-08-25 Glaxo Group Limited Androstane 17α-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
PT105723B (pt) * 2011-05-26 2014-03-24 Hovione Farmaci Ncia S A Método para a preparação de compostos orgânicos biologicamente activos
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
US20150376225A1 (en) * 2013-01-23 2015-12-31 Sphaera Pharma Pvtd. Ltd. Novel compounds of 11beta-hydroxy-steroids for use in mitochondria biogenesis and diseases associated with mitochondrial dysfunction or depletion
JP6781148B2 (ja) 2014-07-23 2020-11-04 スファエラ ファーマ プライベート リミテッド ヒドロキシステロイド化合物、それらの中間体、それらの調製方法、組成物および使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna

Also Published As

Publication number Publication date
EP0334853B1 (de) 1993-06-09
WO1989003390A1 (en) 1989-04-20
DE3786174D1 (de) 1993-07-15
DE3786174T2 (de) 1993-10-21
EP0334853A4 (de) 1990-02-26
EP0334853A1 (de) 1989-10-04

Similar Documents

Publication Publication Date Title
ATE90355T1 (de) Weiche steroide mit anti-entzuendungswirkung.
DK73594A (da) Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater
OA07116A (fr) Esters aromatiques hétérocycliques de stéroïdes, leur préparation et compositions pharmaceutiques les contenant.
ES2059789T3 (es) Esteroides sustituidos con acido fosfinico como inhibidores de la esteroide-5 alfa-reductasa.
UA37196C2 (uk) Лікарська форма для перорального введення для лікування запальних хвороб кишкового тракту
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
FI881223A0 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
ES2058561T3 (es) Esteroides sustituidos con acido fosfonico como inhibidores de la esteroide-5alfa-reductasa.
IE802589L (en) Anti-inflammatory pharmaceutical composition containing¹rosmarinic acid
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
ATE74346T1 (de) Alkensaeurederivate.
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
ES457968A1 (es) Procedimiento para la preparacion de corticoides.
PT86228A (de) Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate
DK146785D0 (da) Pharmaceutisk praeparat med indhold af 9alfa, 11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion
FI894091A7 (fi) Menetelmä fosfonomeripihkahappotetrametyyliesterin ja fosfonomeripihkahappotetraetyyliesterin valmistamiseksi
DE3780105D1 (de) 13alpha-alkylgonan-delta9(11)-5,10-epoxide.
Maeda Studies on relations of temperature of topically used cortico-steroid hormone (beta-methasone) to its therapeutic effect Part I. Clinical investigation on acute otitis media cases
IT7849042A0 (it) Esteri della serie dell'androstano e dell'estrano dotati di proprieta'farmaceutiche e procedimento per laloro preparazione
GR930100234A (el) Νέα στεροειδή με σκελετό πρεγνανίου, φαρμακευτικές συν?έσεις που περιέχουν αυτά και μέ?οδος παρασκευής τους.
FR2598616B1 (fr) Composition pharmaceutique destinee au traitement des phenomenes d'inflammation chez les mammiferes
SE9300082D0 (sv) Novel colon- or ileum-specific steroid derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee